<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font16">for </span>
   <span class="font14">âˆ’. </span>
   <span class="font14">drug </span>
   <span class="font14">with </span>
   <span class="font14">that </span>
   <span class="font14">drugs </span>
   <span class="font13">are </span>
   <span class="font13">COVID- </span>
   <span class="font12">[], </span>
   <span class="font12">coronavirus </span>
   <span class="font12">antiviral </span>
   <span class="font12">which </span>
   <span class="font12">treatment </span>
   <span class="font12">against </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">this </span>
   <span class="font11">{background </span>
   <span class="font11">The </span>
   <span class="font11">virus </span>
   <span class="font11">chloroquine </span>
   <span class="font11">[]. </span>
   <span class="font11">from </span>
   <span class="font11">its </span>
   <span class="font11">(), </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">but </span>
   <span class="font11">margin </span>
   <span class="font11">not </span>
   <span class="font11">viral </span>
   <span class="font11">clinical </span>
   <span class="font11">has </span>
   <span class="font11">more </span>
   <span class="font11">{border-style </span>
   <span class="font11">[,]. </span>
   <span class="font11">was </span>
   <span class="font11">have </span>
   <span class="font11">px;} </span>
   <span class="font11">severe </span>
   <span class="font11">these </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">This </span>
   <span class="font11">can </span>
   <span class="font11">human </span>
   <span class="font11">respiratory </span>
   <span class="font11">Med. </span>
   <span class="font11">[[], </span>
   <span class="font11">combination </span>
   <span class="font11">molecule </span>
   <span class="font11">than </span>
   <span class="font10">could </span>
   <span class="font10">novel </span>
   <span class="font10">molecular </span>
   <span class="font10">new </span>
   <span class="font10">potential </span>
   <span class="font10">protease </span>
   <span class="font10">targets </span>
   <span class="font10">their </span>
   <span class="font10">two </span>
   <span class="font10">(comp. </span>
   <span class="font10">However, </span>
   <span class="font10">also </span>
   <span class="font10">been </span>
   <span class="font10">disease </span>
   <span class="font10">patients </span>
   <span class="font10">selected </span>
   <span class="font10">small </span>
   <span class="font10">use </span>
   <span class="font10">COVID-: </span>
   <span class="font10">[]]. </span>
   <span class="font10">RNA </span>
   <span class="font10">acute </span>
   <span class="font10">approved </span>
   <span class="font10">cell </span>
   <span class="font10">compounds </span>
   <span class="font10">remdesivir </span>
   <span class="font10">therapeutic </span>
   <span class="font10">Chem. </span>
   <span class="font10">highly </span>
   <span class="font10">immune </span>
   <span class="font10">infection </span>
   <span class="font10">molecules </span>
   <span class="font10">still </span>
   <span class="font10">current </span>
   <span class="font10">drug, </span>
   <span class="font10">good </span>
   <span class="font10">i.e., </span>
   <span class="font10">inhibitor </span>
   <span class="font10">only </span>
   <span class="font10">promising </span>
   <span class="font10">properties </span>
   <span class="font10">they </span>
   <span class="font10">Drug </span>
   <span class="font10">available </span>
   <span class="font10">azithromycin </span>
   <span class="font10">based </span>
   <span class="font10">bioactivity </span>
   <span class="font10">certain </span>
   <span class="font10">development </span>
   <span class="font10">drugs, </span>
   <span class="font10">effective </span>
   <span class="font10">found </span>
   <span class="font10">including </span>
   <span class="font10">influenza </span>
   <span class="font10">most </span>
   <span class="font10">px; </span>
   <span class="font10">should </span>
   <span class="font10">similar </span>
   <span class="font10">spike </span>
   <span class="font10">used </span>
   <span class="font10">values </span>
   <span class="font10">well </span>
   <span class="font10">{font-family </span>
   <span class="font10">ACE </span>
   <span class="font10">Res. </span>
   <span class="font10">TableÂ </span>
   <span class="font10">absorption </span>
   <span class="font10">according </span>
   <span class="font10">action </span>
   <span class="font10">activity </span>
   <span class="font10">candidates </span>
   <span class="font10">cells </span>
   <span class="font10">cytokine </span>
   <span class="font10">danoprevir </span>
   <span class="font10">discovery </span>
   <span class="font10">experimental </span>
   <span class="font10">font-size </span>
   <span class="font10">information </span>
   <span class="font10">into </span>
   <span class="font10">inÂ </span>
   <span class="font10">one </span>
   <span class="font10">physicochemical </span>
   <span class="font10">polymerase </span>
   <span class="font10">possible </span>
   <span class="font10">receptor </span>
   <span class="font10">show </span>
   <span class="font10">such </span>
   <span class="font10">syndrome </span>
   <span class="font10">three </span>
   <span class="font10">trials </span>
   <span class="font10">Infect. </span>
   <span class="font10">Lipinskiâ€™s </span>
   <span class="font10">RdRp </span>
   <span class="font10">Rev. </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">TPSA </span>
   <span class="font10">agents </span>
   <span class="font10">arbidol </span>
   <span class="font10">associated </span>
   <span class="font10">because </span>
   <span class="font10">bioavailability </span>
   <span class="font10">both </span>
   <span class="font10">calculated </span>
   <span class="font10">currently </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">efficacy </span>
   <span class="font10">favipiravir </span>
   <span class="font10">hepatitis </span>
   <span class="font10">ivermectin </span>
   <span class="font10">less </span>
   <span class="font10">lopinavir </span>
   <span class="font10">membrane </span>
   <span class="font10">other </span>
   <span class="font10">parameters </span>
   <span class="font10">protein </span>
   <span class="font10">replication </span>
   <span class="font10">research </span>
   <span class="font10">specific </span>
   <span class="font10">therapy </span>
   <span class="font10">transport </span>
   <span class="font10">will </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">CLpro/PLpro </span>
   <span class="font10">EIDD- </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Lipinski-Veber </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">These </span>
   <span class="font10">WHO </span>
   <span class="font10">[,], </span>
   <span class="font10">act </span>
   <span class="font10">agent </span>
   <span class="font10">all </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">approach </span>
   <span class="font10">basis </span>
   <span class="font10">bold </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">candidate </span>
   <span class="font10">descriptors </span>
   <span class="font10">efficient </span>
   <span class="font10">enzyme </span>
   <span class="font10">expected </span>
   <span class="font10">find </span>
   <span class="font10">first </span>
   <span class="font10">future </span>
   <span class="font10">global </span>
   <span class="font10">high </span>
   <span class="font10">hospitalized </span>
   <span class="font10">host </span>
   <span class="font10">important </span>
   <span class="font10">indicate </span>
   <span class="font10">ingavirin </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibits </span>
   <span class="font10">known </span>
   <span class="font10">macrocyclic </span>
   <span class="font10">main </span>
   <span class="font10">many </span>
   <span class="font10">might </span>
   <span class="font10">notably </span>
   <span class="font10">oral </span>
   <span class="font10">original </span>
   <span class="font10">pKa </span>
   <span class="font10">ribavirin </span>
   <span class="font10">ritonavir </span>
   <span class="font10">rules </span>
   <span class="font10">so-called </span>
   <span class="font10">solid; </span>
   <span class="font10">surface </span>
   <span class="font10">system </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">treating </span>
   <span class="font10">umifenovir </span>
   <span class="font10">via </span>
   <span class="font10">when </span>
   <span class="font10">works </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;gt;Â </span>
   <span class="font10">(pKaÂ </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Biol. </span>
   <span class="font10">Both </span>
   <span class="font10">COVID-. </span>
   <span class="font10">COVID-J.Â </span>
   <span class="font10">Engl. </span>
   <span class="font10">FDA </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Pharm. </span>
   <span class="font10">ability </span>
   <span class="font10">active </span>
   <span class="font10">administered </span>
   <span class="font10">adults </span>
   <span class="font10">antimalarial </span>
   <span class="font10">any </span>
   <span class="font10">between </span>
   <span class="font10">bind </span>
   <span class="font10">cLogP </span>
   <span class="font10">case </span>
   <span class="font10">centre </span>
   <span class="font10">characteristics </span>
   <span class="font10">chemical </span>
   <span class="font10">chloroquine, </span>
   <span class="font10">courier; </span>
   <span class="font10">critical </span>
   <span class="font10">cure </span>
   <span class="font10">data </span>
   <span class="font10">design </span>
   <span class="font10">developed </span>
   <span class="font10">discovered </span>
   <span class="font10">drugs. </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">especially </span>
   <span class="font10">experts </span>
   <span class="font10">far </span>
   <span class="font10">form </span>
   <span class="font10">hybrid </span>
   <span class="font10">inhibitors </span>
   <span class="font10">intestinal </span>
   <span class="font10">investigation </span>
   <span class="font10">medicine </span>
   <span class="font10">molecule, </span>
   <span class="font10">molecules, </span>
   <span class="font10">monotherapy </span>
   <span class="font10">much </span>
   <span class="font10">multiple </span>
   <span class="font10">nucleoside </span>
   <span class="font10">obtained </span>
   <span class="font10">old </span>
   <span class="font10">ongoing </span>
   <span class="font10">pandemic </span>
   <span class="font10">pharmacological </span>
   <span class="font10">pneumonia </span>
   <span class="font10">pt;} </span>
   <span class="font10">related </span>
   <span class="font10">repurposed </span>
   <span class="font10">repurposing </span>
   <span class="font10">resource </span>
   <span class="font10">review </span>
   <span class="font10">risk </span>
   <span class="font10">rule </span>
   <span class="font10">rule. </span>
   <span class="font10">safe </span>
   <span class="font10">scores </span>
   <span class="font10">several </span>
   <span class="font10">shown </span>
   <span class="font10">single </span>
   <span class="font10">storm </span>
   <span class="font10">structural </span>
   <span class="font10">studies </span>
   <span class="font10">study </span>
   <span class="font10">there </span>
   <span class="font10">through </span>
   <span class="font10">treatments </span>
   <span class="font10">useful </span>
   <span class="font10">virus, </span>
   <span class="font10">viruses </span>
   <span class="font10">viruses, </span>
   <span class="font10">without </span>
   <span class="font10">work </span>
  </p>
 </body>
</html>
